To sum up, the observations that ATP levels and mitochondrial activity increase in parallel with downregulation of caspase expression after treatment with visfatin support the hypothesis that visfatin is an ani-apoptotic factor that triggers anoikis resistance in ovarian cancer spheroids. The gene discussed is NAMPT; the disease is ovarian carcinoma.